G. Altinkanat Gelmez Et Al. , "Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey," Marmara Medical Journal , vol.34, no.2, pp.127-131, 2021
Altinkanat Gelmez, G. Et Al. 2021. Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey. Marmara Medical Journal , vol.34, no.2 , 127-131.
Altinkanat Gelmez, G., Can, B., Ertürk Şengel, B., Korten, V., & Söyledir, G., (2021). Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey. Marmara Medical Journal , vol.34, no.2, 127-131.
Altinkanat Gelmez, GÜLŞEN Et Al. "Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey," Marmara Medical Journal , vol.34, no.2, 127-131, 2021
Altinkanat Gelmez, GÜLŞEN A. Et Al. "Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey." Marmara Medical Journal , vol.34, no.2, pp.127-131, 2021
Altinkanat Gelmez, G. Et Al. (2021) . "Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey." Marmara Medical Journal , vol.34, no.2, pp.127-131.
@article{article, author={GÜLŞEN ALTINKANAT GELMEZ Et Al. }, title={Determination of fosfomycin susceptibility in carbapenemase producing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey}, journal={Marmara Medical Journal}, year=2021, pages={127-131} }